Boardroom Alpha
10-K primary document
GCTK · Annual Report (Form 10-K) · Filed March 30, 2026

Glucotrack Inc10-K exhibit

ex23-2.htm

 

Exhibit 23.2

 

 

  Fahn Kanne & Co.
  Head Office
  32 Hamasger Street
  Tel-Aviv 6721118, ISRAEL
  PO Box 36172, 6136101
   
  T +972 3 7106666
  F +972 3 7106660
  www.gtfk.co.il

 

CONSENT OF INDEPENDENT

REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated March 31, 2025, with respect to the consolidated financial statements included in the Annual Report of Glucotrack Inc. on Form 10-K for the year ended December 31, 2025. We consent to the incorporation by reference of the said report in the Registration Statements of Glucotrack Inc. on Form S-8 (File No. 333-281627 and File No. 333-290076), Form S-3 (File No. 333-282297 and File No. 333-292695) and Form S-1 (File No. 333-290587).

 

/s/ FAHN KANNE & CO. GRANT THORNTON ISRAEL

 

Tel-Aviv, Israel

 

March 30, 2026

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer